ArticlemedRxiv : the preprint server for health sciences2023
Multi-ancestry meta-analysis of tobacco use disorder prioritizes novel candidate risk genes and reveals associations with numerous health outcomes.
Open access · greenAbstract readPreprint
In one paragraph
Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 6 citations in OpenAlex.
- A single-nucleus transcriptomic atlas of medium spiny neurons in the rat nucleus accumbens.Scientific reports · 2024Article
Corrections and comments
- Updated by
Authors and funding
35 authors at 13 institutions in 3 countries.
Sylvanus ToikumoMental Illness Research, Education and Clinical Center, Crescenz VAMC, Philadelphia, PA, USA.
Mariela V JenningsDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Benjamin K PhamDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Hyunjoon LeePsychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Travis T MallardPsychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Sevim B BianchiDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
John J MeredithDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Laura Vilar-RibóPsychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Heng XuDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Alexander S HatoumDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, Missouri, USA.
Emma C JohnsonDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, Missouri, USA.
Vanessa PazdernikDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Zeal JinwalaDepartment of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Shreya R PakalaDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Brittany S LegerDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Maria NiarchouVanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.
Michael EhinmowoDepartment of Psychology, University of Ibadan, Nigeria.
Penn Medicine BioBank, Million Veteran Program, PsycheMERGE Substance Use Disorder Workgroup
Greg D JenkinsDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Anthony BatzlerDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Richard PendegraftDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Abraham A PalmerDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Hang ZhouDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Joanna M BiernackaDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Brandon J CoombesDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Joel GelernterDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Ke XuDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Dana B HancockBehavioral and Urban Health Program, Behavioral Health and Criminal Justice Division, RTI International, Research Triangle Park, NC, USA.
Nancy J CoxDepartment of Medicine, Division of Genetic Medicine, Vanderbilt University, Nashville, TN, USA.
Jordan W SmollerPsychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Lea K DavisDepartment of Medicine, Division of Genetic Medicine, Vanderbilt University, Nashville, TN, USA.
Amy C JusticeYale University School of Public Health, New Haven, CT, USA.
Henry R KranzlerMental Illness Research, Education and Clinical Center, Crescenz VAMC, Philadelphia, PA, USA.
Rachel L KemberMental Illness Research, Education and Clinical Center, Crescenz VAMC, Philadelphia, PA, USA.
Sandra Sanchez-RoigeDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
University of California San Diego · USVanderbilt University · USMayo Clinic in Florida · USYale University · USHarvard University · USUniversity of Pennsylvania · USMayo Clinic · USWashington University in St. Louis · USMassachusetts General Hospital · USRTI International · USUniversitat Autònoma de Barcelona · ESUniversity of Ibadan · NGVanderbilt University Medical Center · US
Funding
Subject CollectionU10AA008401 · NIAAA · SUNY DOWNSTATE MEDICAL CENTER · PI JAY Arnold TISCHFIELD · 1989 to 2026
$162.7MVanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7MPhenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4MABCD-USA Consortium: Coordinating CenterU24DA041147 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SANDRA A BROWN, TERRY L. JERNIGAN · 2015 to 2026
$54.7MABCD-USA Consortium: Data Analysis, Informatics and Resource CenterU24DA041123 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ANDERS M DALE · 2015 to 2026
$51.5MVANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7MThe Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4MAdolescent Substance Use Initiation: Disentangling neurocognitive risks from consequences using longitudinal and genetically-informed methodsU01DA041120 · NIDA · UNIVERSITY OF MINNESOTA · PI Monica Luciana, Sylia Wilson · 2015 to 2026
$34.5MABCD-USA Consortium: Research ProjectU01DA041089 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Joanna Jacobus, Susan F. Tapert · 2015 to 2026
$31.7MProspective Research Studies of Maturation (PRISM)- Research ProjectU01DA041134 · NIDA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI ERIN MCGLADE, PERRY FRANKLIN RENSHAW · 2015 to 2026
$29.2MABCD-USA CONSORTIUM: RESEARCH PROJECTU01DA041048 · NIDA · CHILDREN'S HOSPITAL OF LOS ANGELES · PI Megan Marie Herting, ELIZABETH R SOWELL · 2015 to 2026
$28.7MSequencing CoreP50DA037844 · NIDA · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2014 to 2023
$27.4MBLRD VA I01 BX004820CSRD VA I01 CX001849NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR001878NCATS NIH HHS UL1 TR002243NCRR NIH HHS S10 RR025141NCRR NIH HHS UL1 RR024975NHGRI NIH HHS T32 HG010464NHGRI NIH HHS U01 HG004798NHGRI NIH HHS U01 HG006378NHLBI NIH HHS U19 HL065962NIAAA NIH HHS K01 AA028292NIAAA NIH HHS K01 AA030083NIAAA NIH HHS K02 AA018755NIAAA NIH HHS P50 AA022537NIAAA NIH HHS R01 AA015416NIAAA NIH HHS U10 AA008401NICHD NIH HHS R01 HD074711NIDA NIH HHS DP1 DA054394NIDA NIH HHS K01 DA051759NIDA NIH HHS P50 DA037844NIDA NIH HHS R01 DA042090NIDA NIH HHS R01 DA050721NIDA NIH HHS R01 DA054869NIDA NIH HHS U01 DA041022NIDA NIH HHS U01 DA041025NIDA NIH HHS U01 DA041028NIDA NIH HHS U01 DA041048NIDA NIH HHS U01 DA041089NIDA NIH HHS U01 DA041093NIDA NIH HHS U01 DA041106NIDA NIH HHS U01 DA041117NIDA NIH HHS U01 DA041120NIDA NIH HHS U01 DA041134NIDA NIH HHS U01 DA041148NIDA NIH HHS U01 DA041156NIDA NIH HHS U01 DA041174NIDA NIH HHS U24 DA041123NIDA NIH HHS U24 DA041147NIGMS NIH HHS P50 GM115305NIGMS NIH HHS RC2 GM092618NIMH NIH HHS R01 MH113362NINDS NIH HHS R01 NS032830
Abstract
Tobacco use disorder (
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.